These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30328258)

  • 1. Prognostic value of impaired hepato-renal function assessed by the MELD-XI score in patients undergoing percutaneous mitral valve repair.
    Spieker M; Hellhammer K; Wiora J; Klose S; Zeus T; Jung C; Saeed D; Horn P; Kelm M; Westenfeld R
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):699-706. PubMed ID: 30328258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).
    Dörr O; Walther C; Liebetrau C; Keller T; Ortlieb RM; Boeder N; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
    Clin Cardiol; 2018 Nov; 41(11):1474-1479. PubMed ID: 30284299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.
    Ailawadi G; Lim DS; Mack MJ; Trento A; Kar S; Grayburn PA; Glower DD; Wang A; Foster E; Qasim A; Weissman NJ; Ellis J; Crosson L; Fan F; Kron IL; Pearson PJ; Feldman T;
    Circulation; 2019 Jan; 139(1):37-47. PubMed ID: 30586701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart team approach in treatment of mitral regurgitation: patient selection and outcome.
    Külling M; Corti R; Noll G; Küest S; Hürlimann D; Wyss C; Reho I; Tanner FC; Külling J; Meinshausen N; Gaemperli O; Wenaweser P; Salzberg SP; Aymard T; Grünenfelder J; Biaggi P
    Open Heart; 2020 Jul; 7(2):. PubMed ID: 32690553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction.
    Gyoten T; Messroghli D; Schenk S; Rochor K; Grimmig O; Just S; Fritzsche D
    Open Heart; 2020; 7(1):e001203. PubMed ID: 32201589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Intraprocedural Pulmonary Venous Flow for Predicting Recurrent Mitral Regurgitation and Clinical Outcomes After Percutaneous Mitral Valve Repair With the MitraClip.
    Ikenaga H; Yoshida J; Hayashi A; Nagaura T; Yamaguchi S; Rader F; Siegel RJ; Kar S; Shiota T
    JACC Cardiovasc Interv; 2019 Jan; 12(2):140-150. PubMed ID: 30678793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience.
    Alozie A; Paranskaya L; Westphal B; Kaminski A; Sherif M; Sindt M; Kische S; Schubert J; Diedrich D; Ince H; Steinhoff G; Öner A
    BMC Cardiovasc Disord; 2017 Mar; 17(1):85. PubMed ID: 28320316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left atrial hemodynamics and left ventricular remodeling -predictors of outcomes after Transcatheter mitral valve repair with the MitraClip device.
    Lazkani M; Sawant AC; Taase A; Khan S; Fang K; Iyer V; Pershad A
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):128-133. PubMed ID: 30244513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Mitral Valve Repair Vs. Stand-Alone Medical Therapy in Patients with Functional Mitral Regurgitation and Heart Failure.
    Benito-González T; Estévez-Loureiro R; Villablanca PA; Armeni P; Iglesias-Gárriz I; Minguito C; Garrote C; de Prado AP; Tundidor-Sanz E; Gualis J; Fernández-Vázquez F
    Cardiovasc Revasc Med; 2020 Jan; 21(1):52-60. PubMed ID: 31326258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
    Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
    Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair.
    Corrigan FE; Chen JH; Maini A; Lisko JC; Alvarez L; Kamioka N; Reginauld S; Gleason PT; Condado JF; Wei JW; Binongo JN; Keegan P; Howell S; Thourani VH; Block PC; Clements SD; Babaliaros VC; Lerakis S
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1905-1913. PubMed ID: 30219407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair.
    Tanaka T; Kavsur R; Spieker M; Iliadis C; Metze C; Horn P; Sugiura A; Baldus S; Kelm M; Nickenig G; Pfister R; Westenfeld R; Becher MU
    Clin Res Cardiol; 2021 Dec; 110(12):1947-1956. PubMed ID: 34254179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).
    Dörr O; Walther C; Liebetrau C; Keller T; Tabert H; Boeder N; Bayer M; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
    Clin Cardiol; 2018 Apr; 41(4):481-487. PubMed ID: 29663512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of percutaneous mitral valve repair with MitraClip for the management of functional mitral regurgitation.
    Marmagkiolis K; Hakeem A; Ebersole DG; Iliescu C; Ates I; Cilingiroglu M
    Catheter Cardiovasc Interv; 2019 Nov; 94(6):820-826. PubMed ID: 30938045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Surgical or Catheter-based Interventions an Option After an Unsuccessful Mitral Clip?
    Kreidel F; Alessandrini H; Wohlmuth P; Schmoeckel M; Geidel S
    Semin Thorac Cardiovasc Surg; 2018; 30(2):152-157. PubMed ID: 29545033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Leaflet-to-Annulus Index on Residual Mitral Regurgitation in Patients Undergoing Edge-to-Edge Mitral Repair.
    Tabata N; Weber M; Sugiura A; Öztürk C; Ishii M; Tsujita K; Nickenig G; Sinning JM
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2462-2472. PubMed ID: 31857016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Frailty on Outcomes in Patients Undergoing Percutaneous Mitral Valve Repair.
    Metze C; Matzik AS; Scherner M; Körber MI; Michels G; Baldus S; Rudolph V; Pfister R
    JACC Cardiovasc Interv; 2017 Oct; 10(19):1920-1929. PubMed ID: 28917516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of the CHA
    Spieker M; Metze C; Kavsur R; Horn P; Iliadis C; Tiyerili V; Pfister R; Becher MU; Westenfeld R
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2562-2564. PubMed ID: 31857031
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation.
    Pawale A; Itagaki S; Parikh A; Pinney SP; Adams DH; Anyanwu AC
    J Thorac Cardiovasc Surg; 2019 May; 157(5):1841-1848.e1. PubMed ID: 31288361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of combined baseline and postprocedural troponin values on clinical outcome following the MitraClip procedure.
    Tabata N; Weber M; Sugiura A; Ishii M; Öztürk C; Tsujita K; Sinning JM; Werner N; Nickenig G
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):E735-E743. PubMed ID: 32212302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.